Science Explorer Interactive view Map
Research facility · Vienna · Austria

Austrian Breast & Colorectal Cancer Study Group

Research works
95
◆ 2% vs 2013–17
Citations
1.7k
17.8 per fractional work
Top-10% rate
18.7%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Austrian Breast & Colorectal Cancer Study Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.08× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.47× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.98× its world share, 0 worksImmunology and Micro…Neuroscience: 0.18× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.04× its world share, 0 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringMathematics: 2.86× its world share, 0 worksMathematicsMedicine: 3.49× its world share, 8 worksMedicineDecision Sciences: 1.87× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.03× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.

Who are the top researchers at Austrian Breast & Colorectal Cancer Study Group?

Ranked on the composite score, Christian Fesl lead among researchers whose main affiliation is Austrian Breast & Colorectal Cancer Study Group.

  1. 1 Christian Fesl Austria · #1,479,333 worldwide 14 citations · 16 works
All ranked researchers at Austrian Breast & Colorectal Cancer Study Group

Which keywords describe research at Austrian Breast & Colorectal Cancer Study Group?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Metastatic Breast Cancer, Breast Cancer, Quality of Life, Clinical Practice Guidelines, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and Radiotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy14▲ 21×18 topics
  2. Metastatic Breast Cancer13▲ 210×2 topics
  3. Breast Cancer12▲ 45×10 topics
  4. Quality of Life11▲ 8.3×14 topics
  5. Clinical Practice Guidelines10▲ 18×10 topics
  6. Chemotherapy-Induced Peripheral Neuropathy9▲ 180×1 topic
  7. Taxanes9▲ 180×1 topic
  8. Radiotherapy8▲ 22×7 topics
  9. Prevention7▲ 20×5 topics
  10. Management7▲ 9.8×6 topics
  11. Neoadjuvant Therapy7▲ 34×4 topics
  12. Molecular Subtypes7▲ 83×3 topics
  13. Survival Analysis7▲ 26×5 topics
  14. Treatment6▲ 5.2×10 topics
  15. Epidemiology6▲ 1.62×21 topics
  16. Dermatological Toxicity6▲ 564×1 topic
  17. Extravasation6▲ 564×1 topic
  18. Prognostic Factors6▲ 14×10 topics
  19. Prognostic Markers6▲ 66×3 topics
  20. Gene Expression6▲ 10×6 topics
  21. Breast Tumours6▲ 121×1 topic
  22. Treatment Response6▲ 121×1 topic
  23. Immune Response5▲ 8.4×5 topics
  24. Antiviral Therapy5▲ 32×3 topics
  25. CDK4/6 Inhibitors5▲ 306×1 topic
  26. Palbociclib5▲ 306×1 topic
  27. Liver Disease4▲ 35×2 topics
  28. Genetic Variation4▲ 13×4 topics
  29. Cancer4▲ 2.9×20 topics
  30. Hepatitis C Virus4▲ 76×1 topic
  31. Ribavirin4▲ 76×1 topic
  32. Angiosarcoma4▲ 228×1 topic
  33. Epithelioid Hemangioendothelioma4▲ 228×1 topic
  34. Hepatocellular Carcinoma3▲ 16×3 topics
  35. Insulin Resistance3▲ 6.4×3 topics
  36. Signaling2▲ 21×3 topics
  37. Nuclear Receptors2▲ 12×3 topics
  38. Rituximab2▲ 14×2 topics
  39. Transcriptional Regulation2▲ 8.8×3 topics
  40. Trastuzumab2▲ 53×2 topics

Which research topics does Austrian Breast & Colorectal Cancer Study Group publish most on?

By volume in 2022–2025: Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Statistical Methods in Clinical Trials and Hepatitis C virus research.

  1. 1 Breast Cancer Treatment Studies Cancer Research 1 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  3. 3 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  4. 4 Hepatitis C virus research Hepatology 0 works
  5. 5 Cancer Risks and Factors Oncology 0 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  7. 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Breast Lesions and Carcinomas Pathology and Forensic Medicine 0 works
  9. 9 HER2/EGFR in Cancer Research Oncology 0 works
  10. 10 Empathy and Medical Education Psychiatry and Mental health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.5%not open66.5%

World: 28% of research is openly available.

with international co-authors26.7%domestic only73.3%

World: 19% is written across borders.

How has Austrian Breast & Colorectal Cancer Study Group's research output changed?

Output in 2018–2022 was 2% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.